Navigating longevity with industry leaders at MIT AgeLab PLAN Forum
MIT AgeLab PLAN Forum, a symposium for financial professionals, imagines new industry around longevity planning.
Stay updated with breaking news from Grail Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIT AgeLab PLAN Forum, a symposium for financial professionals, imagines new industry around longevity planning.
Delaware’s highest court refused to hear billionaire investor Carl Icahn’s appeal of an order to remove confidential information from his lawsuit pending against the DNA-sequencing company Illumina Inc.
(Bloomberg) -- Carl Icahn has decided not to launch a fresh proxy fight at DNA sequencing company Illumina Inc. this year, a person familiar with the matter said.Most Read from BloombergStock Traders Bracing for Worst Shrug Off Hot CPI: Markets WrapOne of the Most Infamous Trades on Wall Street Is Roaring BackUS Core Inflation Tops Forecasts Again, Reinforcing Fed CautionChina Has Never Canceled This Many Shipments of US WheatNY Says Trump Should Post Full Bond During Fraud Case AppealThe activi
Icahn blamed Illumina's management for its handling of the failed acquisition of cancer detection startup Grail Inc.
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Illumina, Inc. (NASDAQ:ILMN) on behalf of